Double trouble: how c-MET and HER2 fuel bladder cancer progression

Abstract Background Bladder cancer is still a prevalent, heterogeneous, and challenging disease. Most cases are non-muscle invasive and carry a significant risk of recurrence and progression despite current advances in therapeutic options. Main c-MET and HER2 belong to the receptor tyrosine kinase f...

Full description

Saved in:
Bibliographic Details
Main Authors: E. M. Naguib, E. F. Ismail, D. I. Badran, M. H. Sherief, T. B. El-Abaseri
Format: Article
Language:English
Published: SpringerOpen 2024-12-01
Series:Egyptian Journal of Medical Human Genetics
Subjects:
Online Access:https://doi.org/10.1186/s43042-024-00618-y
Tags: Add Tag
No Tags, Be the first to tag this record!